• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Topical Imiquimod for the Treatment of Relapsed Cutaneous Langerhans Cell Histiocytosis after Chemotherapy in an Elderly Patient.

作者信息

Imashuku Shinsaku, Kobayashi Miyako, Nishii Yoichi, Nishimura Keisuke

机构信息

Department of Laboratory Medicine, Uji-Tokushukai Medical Center, Uji 611-0042, Japan.

Department of Internal Medicine, Uji-Tokushukai Medical Center, Uji 611-0042, Japan.

出版信息

Case Rep Dermatol Med. 2018 Jan 3;2018:1680871. doi: 10.1155/2018/1680871. eCollection 2018.

DOI:10.1155/2018/1680871
PMID:29535877
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5817217/
Abstract

Diagnosis and treatment of Langerhans cell histiocytosis (LCH) in elderly patients are often difficult. We report here a 61-year-old female suffering from a refractory axillary ulcer for nearly a year, whose biopsy revealed LCH. It was also noted that the patient had other cutaneous papulovesicular eruptions of LCH as well as central diabetes insipidus. The patient was first successfully treated with multiagent chemotherapy (cytosine arabinoside/vinblastine/prednisolone). DDAVP also well controlled diabetes insipidus; however, the axillary ulcer and cutaneous LCH relapsed. Thereafter, we found topical imiquimod to be effective in the treatment of relapsed cutaneous LCH lesions.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f015/5817217/bc42395f5f1d/CRIDM2018-1680871.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f015/5817217/b40b1d91c2d0/CRIDM2018-1680871.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f015/5817217/ed2a5a1ade70/CRIDM2018-1680871.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f015/5817217/bc42395f5f1d/CRIDM2018-1680871.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f015/5817217/b40b1d91c2d0/CRIDM2018-1680871.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f015/5817217/ed2a5a1ade70/CRIDM2018-1680871.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f015/5817217/bc42395f5f1d/CRIDM2018-1680871.003.jpg

相似文献

1
Topical Imiquimod for the Treatment of Relapsed Cutaneous Langerhans Cell Histiocytosis after Chemotherapy in an Elderly Patient.
Case Rep Dermatol Med. 2018 Jan 3;2018:1680871. doi: 10.1155/2018/1680871. eCollection 2018.
2
Langerhans cell histiocytosis associated with breast carcinoma successfully treated with topical imiquimod.朗格汉斯细胞组织细胞增生症伴乳腺癌,局部应用咪喹莫特治疗成功。
Clin Exp Dermatol. 2009 Dec;34(8):e829-32. doi: 10.1111/j.1365-2230.2009.03569.x. Epub 2009 Oct 15.
3
Langerhans' cell histiocytosis (LCH) in adolescence presented with central diabetes insipidus: a case report.青少年朗格汉斯细胞组织细胞增多症(LCH)伴中枢性尿崩症:一例报告
J Med Assoc Thai. 2011 Mar;94 Suppl 2:S135-9.
4
Topical Imiquimod for the Treatment of Childhood Cutaneous Langerhans Cell Histiocytosis.
Pediatr Dermatol. 2016 May;33(3):e184-e185. doi: 10.1111/pde.12829. Epub 2016 Apr 4.
5
Central diabetes insipidus: beware of Langerhans cell histiocytosis!中枢性尿崩症:警惕朗格汉斯细胞组织细胞增多症!
Neth J Med. 2018 Dec;76(10):445-449.
6
Vulvar Lesions in an 8-Year-Old Girl: Cutaneous Manifestations of Multisystem Langerhans Cell Histiocytosis.一名8岁女孩的外阴病变:多系统朗格汉斯细胞组织细胞增多症的皮肤表现
J Pediatr Adolesc Gynecol. 2018 Apr;31(2):153-155. doi: 10.1016/j.jpag.2017.09.010. Epub 2017 Oct 6.
7
Adult multisystem langerhans cell histiocytosis presenting with central diabetes insipidus successfully treated with chemotherapy.成人多系统朗格汉斯细胞组织细胞增生症表现为中枢性尿崩症,经化疗成功治疗。
Endocrinol Metab (Seoul). 2014 Sep;29(3):394-9. doi: 10.3803/EnM.2014.29.3.394. Epub 2014 Sep 25.
8
Successful treatment of adult multisystemic Langerhans cell histiocytosis with psoralen-UV-A, prednisolone, mercaptopurine, and vinblastine.补骨脂素-紫外线A、泼尼松龙、巯嘌呤和长春碱成功治疗成人多系统朗格汉斯细胞组织细胞增多症。
Arch Dermatol. 2008 May;144(5):649-53. doi: 10.1001/archderm.144.5.649.
9
Childhood Langerhans cell histiocytosis: a disease with many faces.儿童朗格汉斯细胞组织细胞增生症:一种具有多种表现的疾病。
World J Pediatr. 2019 Dec;15(6):536-545. doi: 10.1007/s12519-019-00304-9. Epub 2019 Aug 28.
10
Intensification of induction therapy and prolongation of maintenance therapy did not improve the outcome of pediatric Langerhans cell histiocytosis with single-system multifocal bone lesions: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study.强化诱导治疗和延长维持治疗并未改善单系统多灶性骨病变的儿童朗格汉斯细胞组织细胞增生症的结局:日本朗格汉斯细胞组织细胞增生症研究组-02 方案研究的结果。
Int J Hematol. 2018 Aug;108(2):192-198. doi: 10.1007/s12185-018-2444-0. Epub 2018 Mar 28.

引用本文的文献

1
International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults.国际专家共识建议:成人朗格汉斯细胞组织细胞增生症的诊断与治疗。
Blood. 2022 Apr 28;139(17):2601-2621. doi: 10.1182/blood.2021014343.

本文引用的文献

1
Intensified and prolonged therapy comprising cytarabine, vincristine and prednisolone improves outcome in patients with multisystem Langerhans cell histiocytosis: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study.由阿糖胞苷、长春新碱和泼尼松龙组成的强化延长治疗可改善多系统朗格汉斯细胞组织细胞增多症患者的预后:日本朗格汉斯细胞组织细胞增多症研究组-02方案研究结果
Int J Hematol. 2016 Jul;104(1):99-109. doi: 10.1007/s12185-016-1993-3. Epub 2016 Apr 4.
2
Topical Imiquimod for the Treatment of Childhood Cutaneous Langerhans Cell Histiocytosis.
Pediatr Dermatol. 2016 May;33(3):e184-e185. doi: 10.1111/pde.12829. Epub 2016 Apr 4.
3
Progress in understanding the pathogenesis of Langerhans cell histiocytosis: back to Histiocytosis X?朗格汉斯细胞组织细胞增多症发病机制的认识进展:回归组织细胞增生症X?
Br J Haematol. 2015 Apr;169(1):3-13. doi: 10.1111/bjh.13247. Epub 2014 Nov 28.
4
Langerhans cell histiocytosis first presenting in the skin in adults: frequent association with a second haematological malignancy.成人初发皮肤朗格汉斯细胞组织细胞增生症:常与第二种血液系统恶性肿瘤相关。
Br J Dermatol. 2012 Dec;167(6):1287-94. doi: 10.1111/j.1365-2133.2012.11169.x.
5
Langerhans cell histiocytosis.朗格汉斯细胞组织细胞增生症。
J Cutan Med Surg. 2012 Jan-Feb;16(1):45-9. doi: 10.1177/120347541201600109.
6
Topical nitrogen mustard therapy in patients with Langerhans cell histiocytosis.朗格汉斯细胞组织细胞增生症患者的局部氮芥治疗。
Br J Dermatol. 2012 Mar;166(3):642-5. doi: 10.1111/j.1365-2133.2011.10673.x. Epub 2012 Jan 9.
7
Childhood Langerhans cell histiocytosis associated with T cell acute lymphoblastic leukemia.
Eur J Dermatol. 2011 Jan-Feb;21(1):109-10. doi: 10.1684/ejd.2010.1168.
8
Langerhans cell histiocytosis associated with breast carcinoma successfully treated with topical imiquimod.朗格汉斯细胞组织细胞增生症伴乳腺癌,局部应用咪喹莫特治疗成功。
Clin Exp Dermatol. 2009 Dec;34(8):e829-32. doi: 10.1111/j.1365-2230.2009.03569.x. Epub 2009 Oct 15.
9
Topical imiquimod: mechanism of action and clinical applications.局部用咪喹莫特:作用机制及临床应用
Mini Rev Med Chem. 2006 May;6(5):499-503. doi: 10.2174/138955706776876131.
10
Adult cutaneous Langerhans cell histiocytosis responsive to topical imiquimod.
J Am Acad Dermatol. 2006 May;54(5):911-3. doi: 10.1016/j.jaad.2006.01.061.